non–linear regression analysis with a sigmoid-emax model (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
non–linear regression analysis with a sigmoid-emax model
Non–Linear Regression Analysis With A Sigmoid Emax Model, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoid-emax+model+non-linear+regression+analysis/sigmoid+emax+nonlinear+regression+analysis/pm34728559-146-12-14
Average 90 stars, based on 1 article reviews
Non–Linear Regression Analysis With A Sigmoid Emax Model, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoid-emax+model+non-linear+regression+analysis/sigmoid+emax+nonlinear+regression+analysis/pm34728559-146-12-14
Average 90 stars, based on 1 article reviews
non–linear regression analysis with a sigmoid-emax model - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: A novel GABA B receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Discovery of a novel orally active TRPV4 inhibitor: Part 1. Optimization from an HTS hit. Article Snippet: Accepted Manuscript Discovery of a novel orally active TRPV4 inhibitor: Part 1.. Optimization from an HTS hit Yuichi Sami, Masataka Morita, Hirokazu Kubota, Ryoji Hirabayashi, Ryushi Seo, Nobuaki Nakagawa PII: S0968-0896(19)30506-1 DOI: https://doi.org/10.1016/j.bmc.2019.05.041 Reference: BMC 14928 To appear in: Bioorganic & Medicinal Chemistry Received Date: 2 April 2019 Revised Date: 24 May 2019 Accepted Date: 27 May 2019 Please cite this article as: Sami, Y., Morita, M., Kubota, H., Hirabayashi, R., Seo, R., Nakagawa, N., Discovery of a novel orally active TRPV4 inhibitor: Part 1.. Optimization from an HTS hit, Bioorganic & Medicinal Chemistry (2019), doi: https://doi.org/10.1016/j.bmc.2019.05.041 This is a PDF file of an unedited manuscript that has been accepted for publication. |